Sugi Predict

Sugi Predict / Compounds / SCHEMBL10128263

SCHEMBL10128263

SCHEMBL10128263

CC(C)(C)c1ccc(-c2ccc3c(c2)c2cc(-c4ccc(C(C)(C)C)cc4)ccc2n3-c2ccc(-c3nnc4c5ccccc5ccn34)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ RXRA P19793 1/20 0.35
▸ RXRB P28702 1/20 0.35
▸ RXRG P48443 1/20 0.35
▸ OPRD1 P41143 4/20 0.35
▸ OPRM1 P35372 1/20 0.35
▸ PTGES O14684 1/20 0.34
▸ CCR4 P51679 1/20 0.33
▸ HSD11B1 P28845 1/20 0.33
▸ ADORA2A P29274 1/20 0.32
▸ TNKS O95271 1/20 0.32
▸ TNKS2 Q9H2K2 1/20 0.32
▸ AVPR1A P37288 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10128239 0.94 MAPT (0.39) ALDH1A1MAPTKDM4EMEN1LMNA
SCHEMBL10128268 0.90 ALDH1A1 (0.42) ALDH1A1MAPTKDM4EKMT2ANPSR1
SCHEMBL10128242 0.90 HSD11B1 (0.38) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL10128252 0.90 HSD11B1 (0.38) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL10128240 0.88 KDM4E (0.37) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL10128254 0.88 HSD11B1 (0.37) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL10128260 0.88 TUBB4A (0.36) ALDH1A1MAPTKMT2AOPRD1HSD11B1
SCHEMBL10128251 0.87 TUBB4A (0.37) ALDH1A1MAPTKMT2AOPRD1HSD11B1
SCHEMBL10148971 0.86 MAPT (0.36) ALDH1A1MAPTKDM4EMEN1LMNA
SCHEMBL10155413 0.86 ALDH1A1 (0.35) ALDH1A1MAPTKDM4EMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 — — US disclosed
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 — — US disclosed
WO-2012017842-A1 TRIAZOLE DERIVATIVE, HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-02-09 — — WO disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device HTR3D, KCNQ4, KCNQ3 ALDH1A1 1032/4885MAPT 1271/4885KDM4E 2008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.